Pfiz­er is mak­ing a $500M state­ment to­day: Here’s how you be­come a lead play­er in the boom­ing gene ther­a­py sec­tor

Three years ago, Pfiz­er an­ted up $150 mil­lion in cash to buy Bam­boo Ther­a­peu­tics in Chapel Hill, NC as it cau­tious­ly stuck a toe in the small gene ther­a­py pool of re­search and de­vel­op­ment.

Com­pa­ny ex­ecs fol­lowed up a year lat­er with a $100 mil­lion ex­pan­sion of the man­u­fac­tur­ing op­er­a­tions they picked up in that deal for the UNC spin­out, which came with $495 mil­lion in mile­stones.

And now they’re re­al­ly go­ing for it.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER